Amaze Holdings, Inc. filings document the regulatory record of a Nevada public company operating a creator-powered commerce business. Its Securities Act registration statements describe securities offering, capital-structure and corporate information, while Form 8-K reports furnish shareholder communications, investor presentations, strategic collaboration announcements and other material-event disclosures.
Proxy materials cover board elections, auditor ratification, executive-compensation advisory votes, equity incentive plan approval, authorized-share amendments and NYSE American share-issuance approvals for convertible note conversions. Other filings include a Form 12b-25 notice for a delayed annual report and disclosures concerning litigation involving a subsidiary and historical contractual obligations.
Amaze Holdings, Inc. (AMZE) registered up to 50,000,000 shares of common stock for resale by C/M Capital Master Fund, LP. The shares may be issued to the fund under an equity line that lets Amaze choose, subject to contract conditions, whether to sell shares during a 36-month term beginning when applicable conditions are satisfied. Amaze may receive up to $100 million in gross proceeds from those initial sales; it receives no proceeds from the fund’s later resales.
Fixed and VWAP purchases require the prior business day’s closing price to be at least $0.01; fixed purchases are limited to $500,000 each and $10 million in aggregate per day. Purchase prices are 95% of specified lower-of market-price benchmarks. Separately, the $2 million commitment fee is payable in 1,000,000 Series F preferred shares convertible into up to 80,000,000 common shares at $0.025 per share, subject to ownership limits and conversion restrictions.
Amaze’s common stock was delisted from NYSE American effective October 12, 2026, and management reported material weaknesses in internal controls as of December 31, 2025. The prospectus says equity-line issuances would dilute existing holders and significant resales could pressure the share price.
Amaze Holdings, Inc. (AMZE) says its board and a majority stockholder approved amendments that would increase authorized common shares from 93,750,000 to 4,000,000,000 and permit one or more reverse stock splits. Each split may be set at a ratio from 1-for-2 to 1-for-500, with the combined ratio capped at 1-for-500; the board will determine the ratio or ratios, implementation and timing.
The company had 36,137,566 common shares outstanding as of October 14, 2026. The company says additional authorized shares may support purposes including raising capital and that new issuances may dilute existing holders. The actions were approved by written consent; no further stockholder approval is required. They may become effective no sooner than 20 calendar days after the definitive information statement is mailed.
Amaze Holdings, Inc. registered up to 50,000,000 shares of common stock for resale by C/M Capital Master Fund, LP. After applicable agreement conditions are met, Amaze may issue shares to the fund at its discretion during a 36-month term. Amaze receives no proceeds from resales but may receive up to $100 million in aggregate gross proceeds from its sales to the fund, intended for working capital and general corporate purposes. Fixed Purchase pricing is 95% of the lower of the five-business-day VWAP and the prior business day’s lowest sale price; each Fixed Purchase is capped at $500,000, with aggregate Fixed Purchases capped at $10 million per day.
The fund’s ownership cap is 4.99%, or 9.99% after 61 days’ prior notice. As of October 15, 2026, 36,137,566 shares of common stock were outstanding; if all 50,000,000 registered shares were issued and outstanding as of that date, they would represent approximately 58.0% of the total. AMZE was delisted from NYSE American effective October 12, 2026 and is quoted on OTC Pink; Amaze intends to apply for OTCQB quotation. Management concluded internal controls were not effective as of December 31, 2025, due to material weaknesses continuing since at least 2021.
Amaze Holdings, Inc. entered into an agreement with C/M Capital Master Fund, LP under which it may sell up to $100 million of newly issued common stock, subject to contractual conditions. After applicable conditions are met, including effectiveness of a resale registration statement, the company may direct purchases at its discretion; the 36-month term begins on the Commencement Date. Fixed purchases are priced at 95% of the lower of the VWAP for the preceding five business days and the prior business day’s lowest sale price, capped at $500,000 per purchase and $10,000,000 in aggregate fixed purchases per day.
At execution, Amaze agreed to pay a $2,000,000 commitment fee in 1,000,000 Series F preferred shares, each with $2.00 stated value and convertible at $0.025 per share into currently 80,000,000 common shares. Conversion is subject to a 4.99% beneficial-ownership limit (9.99% after 61 days’ prior notice) and may not occur before the earliest of the 12-month anniversary, termination of the agreement, or company written consent. Separately, one Series X preferred share has voting power equal to 51% of votes eligible at a stockholder meeting, solely on proposals to increase authorized common shares to a maximum of 4,000,000,000 or effect reverse splits from 1-for-2 to 1-for-500, with a combined cap of 1-for-500; its holder can approve them without other stockholder votes.
Amaze Holdings, Inc. (AMZE) received board and stockholder approval on October 12, 2026, to increase authorized common shares from 93,750,000 to 4,000,000,000. The approvals also permit one or more reverse stock splits at ratios from 1-for-2 to 1-for-500, with the combined ratio capped at 1-for-500; the board will determine the ratio and timing. No further stockholder approval is required. The amendments may take effect no sooner than 20 calendar days after the Definitive Information Statement is mailed.
The company says its common stock was recently suspended from trading on NYSE American and will be delisted, and it intends to apply for quotation on the OTCQB Venture Market. The board says the reverse split may help the company satisfy OTCQB quotation requirements, but cannot assure that the split will produce a sustained or proportionate increase in the share price.
Amaze Holdings, Inc. (AMZE) received written notice on September 29, 2026, that NYSE American would begin proceedings to delist its common stock and suspend trading immediately. The exchange cited the stock’s low selling price, and Amaze will not appeal. NYSE American filed Form 25 on October 1, 2026; delisting will become effective 10 days after that filing.
After suspension, AMZE is quoted on the OTC Pink Limited Market, and Amaze intends to apply for quotation on the OTCQB Venture Market. Amaze stated that OTC markets are significantly more limited than NYSE American and likely mean less liquidity, which could further depress the trading price. It said the transition will not affect business operations.
Amaze Holdings, Inc. (AMZE) is identified as the issuer in a Form 25 notice regarding removal of its common stock from listing and/or registration on NYSE American LLC. The notice includes language stating that the exchange complied with its rules to strike the class, as well as language that the issuer complied with requirements governing voluntary withdrawal.
AMAZE HOLDINGS, INC. (symbol: AMZE) is the issuer of record for a Form 8-K filing submitted to the SEC.
Amaze Holdings, Inc. reported that board member Aaron Day resigned from the company’s board of directors, effective immediately on August 14, 2026. The company states that Mr. Day’s resignation did not result from any disagreement regarding its operations, policies, or practices. The report is signed by Interim Chief Executive Officer Joel Krutz on behalf of Amaze Holdings, Inc.